Analysis of a Questionnaire Survey regarding Current Conditions against Exposure to Anticancer Drugs and Reports of Cancer Chemotherapy at Outpatient Departments in Japan
[Background] Medical staff have many occasions to be exposed to anticancer drugs (ACDs) in the process of performing cancer chemotherapy. Although guidelines for the safe handling of ACDs have been published, actual measures against exposure to ACDs differ between hospitals, and no surveillance data regarding the conditions of each hospital in relation to performing chemotherapy in Japan are available. [Methods] To understand current measures against exposure to ACDs and problems related to cancer chemotherapy at outpatient departments, we conducted a questionnaire survey on doctors, pharmacists, and nurses in 10 leading hospitals for cancer chemotherapy in Japan. [Results] Responses were received from all 10 institutions. The hospital pharmacists prepared all ACDs for outpatients in each institution. All hospitals took basic measures against ACD exposure, such as using personal protective equipment and penetration-resistant waste containers. Conditions against exposure to ACDs generally improved between 2012 and 2015, especially in terms of conveyance of ACDs and use of a closed-system drug transfer device. However, no measures linking ACDs with administration routes or injection sites were commonly taken in any of the hospitals in 2015. [Conclusions] Conditions against ACD exposure improved between 2012 and 2015, possibly because new guidelines were issued. To improve measures for ACD exposure in Japan, preparing more appropriate manuals and offering more opportunities to medical staff for continuing education are considered important.
References
[1]
Stewart, B.W. and Wild, C.P. (2014) World Cancer Report 2014. World Health Organization Press, Geneva.
[2]
Health and Social Statistics Division (2015) Vital Statistics, Statistics and Information Department Minister’s Secretariat Ministry of Health, Labour and Welfare, Japan.
[3]
ASHP (American Society of Health-System Pharmacists) (1990) ASHP Technical Assistance Bulletin on Handling Cytotoxic and Hazardous Drugs. American Journal of Health-System Pharmacy, 47, 1033-1049.
[4]
NIOSH (National Institution of Occupational Safety and Health) (2004) NIOSH Alert. Preventing Occupational Exposures to Antineoplastic and Other Hazardous Drugs in Health Care Settings. NIOSH, Atlanta.
[5]
ONS (Oncology Nursing Society) (2011) Safe Handling of Hazardous Drugs. 2nd Edition, ONS, Pittsburgh.
[6]
Krepinsky, A., Bryant, D.W., Davison, L., et al. (1990) Comparison of Three Assays for Genetic Effects of Antineoplastic Drugs on Cancer Patients and Their Nurses. Environmental and Molecular Mutagenesis, 15, 83-92.
https://doi.org/10.1002/em.2850150205
[7]
Valanis, B.G., Vollmer, W.M., Labuhn, K.T. and Glass, A.G. (1993) Acute Symptoms Associated with Antineoplastic Drug Handling among Nurses. Cancer Nursing, 16, 288-295. https://doi.org/10.1097/00002820-199308000-00005
[8]
Kopjar, N. and Garaj-Vrhovac, V. (2001) Application of the Alkaline Comet Assay in Human Biomonitoring for Genotoxicity: A Study on Croatian Medical Personnel Handling Antineoplastic Drugs. Mutagenesis, 16, 71-78.
https://doi.org/10.1093/mutage/16.1.71
[9]
Jakab, M.G., Major, J. and Tompa, A. (2001) Follow-Up Genotoxicological Monitoring of Nurses Handling Antineoplastic Drugs. Journal of Toxicology and Environmental Health, 62, 307-318. https://doi.org/10.1080/152873901300018011
[10]
OSHA (Occupational Safety and Health Administration) (1986) OSHA Work-Practice Guidelines for Personnel Dealing with Cytotoxic (Antineoplastic) Drugs. OSHA, Washington DC.
[11]
ISOPP (International Society of Oncology Pharmacy Practitioners) (2007) Standards of Practice: Safe Handling of Cytotoxics. ISOPP, North Vancouver.
[12]
Japanese Society of Hospital Pharmacists (2014) Manual of Preparations for Anti-Cancer Drugs. 3rd Edition, Japanese Society of Hospital Pharmacists, Jiho.
[13]
ASHP (American Society of Health-System Pharmacists) (2006) ASHP Guidelines on Hazardous Drugs. ASHP, Bethesda.
[14]
Sessink, P.J., Trahan, J. and Coyne, J.W. (2013) Reduction in Surface Contamination with Cyclophosphamide in 30 US Hospital Pharmacies Following Implementation of a Closed-System Drug Transfer Device. Hospital Pharmacy, 48, 204-212.
https://doi.org/10.1310/hpj4803-204
[15]
Sato, J., Mori, M., Kumagai, M., et al. (2012) Journal of Japanese Society of Hospital Pharmacists, 48, 441-444. (In Japanese)
[16]
Davidson, C.S., Green, C.F., Gibbs, S.G., et al. (2013) Performance Evaluation of Selected N95 respirators and Surgical Masks When Challenged with Aerosolized Endospores and Inert Particles. Journal of Occupational and Environmental Hygiene, 10, 461-467. https://doi.org/10.1080/15459624.2013.818243
[17]
Japan Society of Cancer Nursing (JSCN), Japan Society of Medical Oncology (JSMO) and Japan Society of Pharmaceutical Oncology (JASPO) (2015) The First Edition of JSCN/JSMO/JASPO Joint Guidelines for Safe Handling of Cancer Chemotherapy Drugs (Joint Guideline). (In Japanese)